Jonas Ekblom, Ph.D. Chief Executive Officer
Dr. Jonas Ekblom has over 20 years of experience from the life science sector, with a focus in pharmacology and drug development. He has managed R&D programs in multiple fields of medical technology in several therapeutic areas. Most recently, Jonas Ekblom has served as Chief Executive Officer of Bows Pharmaceuticals AG, a Swiss drug delivery company. Prior to that, he has held senior management positions in Pharmacia, Biovitrum, Sequenom and Invitrogen. Jonas has a strong track record in strategic R&D management, portfolio evaluation and licensing of programs in stages from pre-clinical to Phase 2 clinical trials. Jonas Ekblom has founded several start-up companies including Snakemind and Anaborex Inc. He has published over 60 peer-reviewed articles and holds a position as an Associate Professor in Pharmacology at Uppsala University, Sweden. Jonas also serves on the board of directors of The Releef Initiative, which is an international humanitarian non-profit organization.
Margit Mahlapuu, Ph.D. Chief Scientific Officer
Dr. Margit Mahlapuu has more than 10 years of experience in the biotech and pharma industry. She started her career as a Post Doctoral Fellow at AstraZeneca (2001-2002) after her doctorate degree in Molecular and Cell Biology. Hereafter she was Project Leader Arexis, a Swedish drug discovery company (2002- 2005) and Project Manager R&D, at Biovitrum (2005-2007). In 2007 she joined PharmaSurgics as Chief Scientific Officer and is currently also Managing Director. Margit has authored and co-authored 20 papers in scientific journals and has 4 pending patent applications. Since 2011 she is Associated Professor in Medicine at the Sahlgrenska Academy, Göteborg University.
Ulrika Wennberg Chief Operating Officer
Ulrika Wennberg has over 15 years of business experience as an entrepreneur, project manager, management consultant, controller and business leader. She has broad experience from several different industries, e.g. consulting, IT, media and biotech. Her previous position was as CFO and subsequently CEO at Jederstrom Pharmaceuticals AB. Ulrika holds a Master’s degree in Management.
Mattias Münnich Director Business Operations
Mattias Münnich has over 10 years experience of starting and developing companies in different industries. He is co-founder of PharmaSurgics and has been a part of the development of the PXL-01 platform from the start in 2005. His responsibilities have included strategic planning, fiscal management and execution of the development initiative, as well as planning for commercialization. Mattias holds a Bachelor’s degree in Business Administration and a Master of Science in Technology.